Abstract

Polypoidal choroidal vasculopathy (PCV) and neovascular age-related macular degeneration (nAMD) share some similarity in clinical imaging manifestations. However, their disease entity and treatment strategy as well as visual outcomes are very different. To distinguish these two vision-threatening diseases is somewhat challenging but necessary. In this study, we propose a new artificial intelligence model using an ensemble stacking technique, which combines a color fundus photograph-based deep learning (DL) model and optical coherence tomography-based biomarkers, for differentiation of PCV from nAMD. Furthermore, we introduced multiple correspondence analysis, a method of transforming categorical data into principal components, to handle the dichotomous data for combining with another image DL system. This model achieved a robust performance with an accuracy, sensitivity, specificity, and area under the receiver operating characteristic curve of 83.67%, 80.76%, 84.72%, and 88.57%, respectively, by training nearly 700 active cases with suitable imaging quality and transfer learning architecture. This work could offer an alternative method of developing a multimodal DL model, improve its efficiency for distinguishing different diseases, and facilitate the broad application of medical engineering in a DL model design.

Highlights

  • Polypoidal choroidal vasculopathy (PCV) and neovascular age-related macular degeneration share some similarity in clinical imaging manifestations

  • There is no doubt that the multi-modal deep learning (DL) model has draw more attention in the development of medical Artificial intelligence (AI)

  • The present study introduced a novel bi-modal DL model for clinical ophthalmologists, which combined the DL algorithm and multiple correspondence analysis (MCA) transformation data using an ensemble stacking technique to classify PCV and neovascular age-related macular degeneration (nAMD)

Read more

Summary

Introduction

Polypoidal choroidal vasculopathy (PCV) and neovascular age-related macular degeneration (nAMD) share some similarity in clinical imaging manifestations. Their disease entity and treatment strategy as well as visual outcomes are very different. Polypoidal choroidal vasculopathy (PCV) is currently considered a subtype of pachychoroid spectrum disease with clinical imaging features similar to those of typical neovascular age-related macular degeneration (nAMD)[1,2]. NAMD and PCV have some similarity in clinical imaging manifestations, their disease entities, treatment strategies as well as outcomes are different. Eyes with PCV are more prone to manifesting massive subretinal hemorrhage, recurrent hemorrhagic/serous pigment epithelial detachment (PED), or breakthrough vitreous hemorrhage compared to ­nAMD3,4 To distinguish these two vision-threatening diseases is somewhat challenging but necessary. We combine CFPs and OCT biomarkers by applying Google’s ­EfficientNet[18] and demonstrate the feasibility and efficacy of this novel DL model by stacking technique to distinguish between PCV and AMD

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.